|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Net revenue | ||||
| Cost of goods sold | ||||
| Gross profit | ||||
| Operating expenses: | ||||
| Research and development | ||||
| Selling, general, and administrative | ||||
| Legal settlement | ||||
| Total operating expenses | ||||
| Operating loss | ||||
| Other income (expense): | ||||
| Other income (expense), net | ||||
| Loss on early extinguishment of debt | ||||
| Interest expense, net | ||||
| Total other expense, net | ||||
| Loss before income taxes | ||||
| Income tax expense (benefit) | ||||
| Net loss | ||||
| Net (loss) income attributable to common stockholders | ||||
| Foreign currency translation adjustment | ||||
| Comprehensive loss | ||||
| Weighted average number of shares of common stock outstanding: | ||||
| Basic (in shares) | ||||
| Diluted (in shares) | ||||
| Net loss per share attributable to common stockholders: | ||||
| Basic (in dollars per share) | ||||
| Diluted (in dollars per share) |
Loading...